History of prostate cancer in relatives may increase risk of breast cancer
the ONA take:
A recent study explored the impact of having a family history of cancer on a person’s risk of developing cancer, with a new twist.
Women with a family history of prostate cancer in first-degree relatives (fathers, brothers, sons) may have a higher risk of developing breast cancer.
Evidence indicates that having a family history of breast or prostate cancer increases a person’s risk of developing the same disease; however, the relationship between breast and prostate cancer within families is not well known.
Researchers at the Barbara Ann Karmanos Cancer Institute reviewed the cases from 78,171 women who enrolled in the Women’s Health Initiative Observational Study between 1993 and 1998 and did not have breast cancer at the start of the study.
At the end of the study, a total of 3,506 cases of breast cancer were diagnosed. Study results linked a family history of prostate cancer in first-degree relatives with a 14% increase in risk of developing breast cancer.
The researchers noted that patients and clinicians may not consider cancers in family members of the opposite sex.
However, these results suggest that clinicians should take a complete family history of all cancers, particularly among first-degree relatives, to assess a patient’s risk for developing cancer.
Women with a family history of prostate cancer in first-degree relatives may have a higher risk of developing breast cancer.
- Cholesterol-Lowering Drugs May Prevent Breast Cancer Recurrence
- Blood Test Predicts Stem Cell Transplant Success in Myelodysplastic Syndrome
- Idelalisib Increases Progression-Free Survival in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia
- Trends in Behaviors, Medical Practice Indicate Mortality From Melanoma Will Decline
- Immunotherapy and the Future of Prostate Cancer Treatment
- Survivors Reporting Chronic Neuropathic Pain Struggle to Retain Jobs
- Timing of Chemotherapy Infusion Affects Inflammatory Response to Chemotherapy
- Postoperative Gemcitabine Plus Capecitabine: A New Standard of Care for Pancreatic Cancer
- Blood-Forming Stem Cell Transplants (Fact Sheet)
- Nut Consumption Inversely Associated With Lung Cancer Risk
- Use of Checkpoint Inhibitors in Urothelial Carcinoma
- Chemo + Radiotherapy Efficacious in Muscle-invasive Bladder Cancer
- Elderly with NSCLC Can Tolerate Aggressive Radiation Therapy Treatments
- Colorectal Cancer Risk Higher With Poor Metabolic Health vs Increased Weight
- Best Approach to Infection and Tumor Treatment: Contain or Eliminate?
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|